In addition, knockdown of CDK5 can decrease the cellular DNA damage repair ability and inhibit tumor cell growth [57], suggesting that inhibition of CDK5 in combination with traditional chemotherapeutic agents may be an effective strategy for cancer treatment. This evidence concerns the gene CDK5 and neoplasm.